RMAH Farmaceutica REMEDIA S.A.

0.1657USD0.8080 RON · BVB-0.74%Mkt Cap: 15.53M USDP/E: 20.20

Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company pr…

Key Statistics

Company
Market Cap15.53M USD
Enterprise Value7.86M USD
Revenue (TTM)151.90M USD
Gross Profit12.42M USD
Net Income (TTM)1.65M USD
Revenue/Share1.59 USD
Last Price0.1657 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees210
CountryRO
SectorHealthcare
IndustryMedical Distribution
ISINRORMAHACNOR2
Valuation
P/E (Trailing)20.20
P/E (Forward)—
PEG—
EV/EBITDA3.96
EV/Revenue0.05
P/S0.10
P/B0.95
EPS (TTM)0.0082 USD
EPS (Forward)—
52W Range
0.141545% of range0.1949
52W High0.1949 USD
52W Low0.1415 USD
Profitability
Gross Margin7.97%
Oper. Margin1.00%
EBITDA Margin1.31%
Profit Margin1.06%
ROE10.10%
ROA2.10%
ROIC33.30%
ROCE17.60%
Growth
Revenue Growth0.30%
Earnings Growth-80.30%
Cash Flow & Leverage
Operating CF173.83K USD
CapEx (TTM)—
FCF Margin2.06%
FCF Yield20.13%
Net Debt-7.78M USD
Net Debt/EBITDA-3.92
Net Debt/FCF-2.49
Balance Sheet
Debt/Equity0.01
Current Ratio1.10
Quick Ratio0.91
Book Value/Sh0.17 USD
Cash/Share0.08 USD
Dividends
Fwd Div Rate0.01 USD
Trail. Div Rate0.00 USD
Div. Yield6.14%
5Y Avg Yield7.17%
Payout Ratio95.69%
Ex-Div DateSep 14, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.93.70M
Float16.79M
Insiders80.55%
Institutions0.00%
Technical
SMA 500.1576 (+5.2%)
SMA 2000.1716 (-3.4%)
Beta-0.02
S&P 52W Chg12.00%
Avg Vol (30d)23.27K
Avg Vol (10d)18.44K
Technical Indicators
RSI (14)56.1
MACD0.0098
MACD Signal0.0101
MACD Hist.-0.0002
BB Upper0.1702 USD
BB Middle0.1646 USD
BB Lower0.1590 USD
BB Width6.82%
ATR (14)0.0030 USD
Vol Ratio (20d)1.35x

About Farmaceutica REMEDIA (BVB: RMAH)

›

Farmaceutica REMEDIA (BVB: RMAH) is listed on Bucharest Stock Exchange, where its shares trade in RON. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 210 employees.

The shares were at 0.8080 RON on 19 November 2026, up 14.1% over 52 weeks. Its 52-week range is 0.6900 RON to 0.9500 RON: the price is 14.9% below the high and 17.1% above the low.

At a market capitalisation of 75.71M RON, it trades at 20.2 times trailing earnings. The median trailing P/E of its 18 largest Medical Distribution peers is 21.7, so RMAH is valued in line with them. It pays a dividend yielding 6.14% (it pays out 96% of its earnings), against a median of 1.96% among the dividend payers in that peer group.

Farmaceutica REMEDIA reports return on equity of 10.1%, an operating margin of 1.0% and flat revenue year over year.

It holds more cash than debt, a net cash position of 37.94M RON. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.